All In Biotech

Drug Trial Radar · NCT04908553

Study on the Safety and Effectiveness of Remimazolam Tosilate for Injection for Short-term Elective Surgery in Adults

Safety and Dose Exploration of Remimazolam Tosilate for Injection for Induction and Maintenance of General Anesthesia Intubation for Elective Short-term Surgery in Adults: a Multi-center, Randomized, Double-blind Clinical Study

Last checked: Nov 20, 2026Latest source record: Jun 29, 2025 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedPivotal-lookingRandomized with 650 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

650

Actual

Start

Jul 1, 2021

Primary completion

Mar 30, 2025

Study completion May 31, 2025

Sponsor

Lead sponsor
Tongji HospitalAcademic, hospital or other
Sponsor type
Academic, hospital or other
First posted
Jun 1, 2021

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 4
Allocation
Randomized
Model
Parallel
Masking
Double (participant, investigator)
Primary purpose
Other
FDA-regulated drug
No
Who can join
All sexes, from 18 years, up to 65 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

Research objective: To explore the safety and dose exploration of Remimazolam Tosilate for Injection for induction and maintenance of general anesthesia in elective short-term surgery in adults. Main research indicators:(1)Success rate of sedation during induction and maintenance of general anesthesia with remazolam tosylate;(2)The incidence and severity of hypotension in the induction and maintenance phases Study design: Multi-center, randomized, double-blind clinical study. Subject population: patients undergoing elective short-term surgery. Research data collection period: The subject signs the consent form until discharge or death in the hospital or withdrawal from the research. Number of research centers/sample size: It is planned to enroll 600 patients from 11 hospitals. Research process: The researchers will include patients who meet the enrollment criteria and agree to participate in the investigation of the support laryngoscope surgery and minor head and neck surgery patients from the elective surgery patients.

Conditions

  • Hypotension During Surgery

Interventions

  • Remimazolam Tosilate for Injection 0.1mg/kgDrug

    Remimazolam Tosilate for Injection 0.1mg/kg at induction

  • Remimazolam Tosilate for Injection 0.15mg/kgDrug

    Remimazolam Tosilate for Injection 0.15mg/kg at induction

  • Remimazolam Tosilate for Injection 0.2mg/kgDrug

    Remimazolam Tosilate for Injection 0.2mg/kg at induction

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Incidence of hypotension during the anesthesiaTime frame: during the anesthesia procedure
  2. The rate of Successful sedation during the anesthesiaTime frame: during the anesthesia procedure

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • TongjiHospital

    Wuhan, China

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.